Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |